Vivo Capital Surplus Fund VIII, L.P.
Insider CIK 1628048 · IMPL 10% owner · MNLO 10% owner · BOLT 10% owner · CRNX 10% owner · ALGS 10% owner · TERN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-03 | 2024-04-03 | 4,149 | $6.20 | $25.7K | 268,573 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-03 | 2024-04-03 | 30,047 | $6.20 | $186.3K | 1,945,015 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-03 | 2024-04-03 | 103,870 | $6.20 | $644.0K | 4,023,741 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-02 | 2024-04-03 | 76,346 | $6.65 | $507.7K | 4,127,611 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-02 | 2024-04-03 | 3,050 | $6.65 | $20.3K | 272,722 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-02 | 2024-04-03 | 22,084 | $6.65 | $146.9K | 1,975,062 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-01 | 2024-04-03 | 136,255 | $6.99 | $952.4K | 4,203,957 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-01 | 2024-04-03 | 39,411 | $6.99 | $275.5K | 1,997,146 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-01 | 2024-04-03 | 5,451 | $6.99 | $38.1K | 275,772 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | S Sale | 2023-12-19 | 2023-12-19 | 208,657 | $0.08 | $16.7K | 2,029,495 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | S Sale | 2023-12-19 | 2023-12-19 | 28,632 | $0.08 | $2.3K | 280,294 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | S Sale | 2023-12-18 | 2023-12-19 | 28,682 | $0.11 | $3.2K | 308,926 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | S Sale | 2023-12-18 | 2023-12-19 | 209,029 | $0.11 | $23.0K | 2,238,152 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | S Sale | 2023-12-15 | 2023-12-19 | 87,934 | $0.29 | $25.5K | 2,447,181 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | S Sale | 2023-12-15 | 2023-12-19 | 12,066 | $0.29 | $3.5K | 337,608 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 1,457 | $0.90 | $1.3K | 111,662 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 1,707 | $0.90 | $1.5K | 1,952,302 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 236 | $0.90 | $212 | 269,587 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-20 | 2023-11-20 | 27,465 | $0.92 | $25.3K | 1,954,009 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-20 | 2023-11-20 | 3,792 | $0.92 | $3.5K | 269,823 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-20 | 2023-11-20 | 23,443 | $0.92 | $21.6K | 113,119 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 8,211 | $0.93 | $7.6K | 1,981,474 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 7,009 | $0.93 | $6.5K | 136,562 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 1,134 | $0.93 | $1.1K | 273,615 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-16 | 2023-11-20 | 6,429 | $0.96 | $6.2K | 143,571 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-16 | 2023-11-20 | 1,040 | $0.96 | $998 | 274,749 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-16 | 2023-11-20 | 7,531 | $0.96 | $7.2K | 1,989,685 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-12-23 | 2022-12-23 | 758,620 | $7.25 | $5.50M | 4,340,212 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-09-07 | 2022-09-08 | 600,000 | $3.60 | $2.16M | 3,581,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-16 | 1,500,000 | $2.42 | $3.63M | 1,500,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-16 | 1,500,000 | $2.42 | $3.63M | 2,981,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-15 | 2022-08-16 | 1,218 | $2.99 | $3.6K | 1,481,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-12 | 2022-08-16 | 1,123,021 | $2.98 | $3.35M | 1,480,374 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 11,628,174 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 5,162,969 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 995,714 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 7,206,216 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 713,064 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 0 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 0 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 1,073,308 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 7,772,634 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 1,605,711 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-04-27 | 2021-04-29 | 69,380 | $15.00 | $1.04M | 349,674 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-04-27 | 2021-04-29 | 505,620 | $15.00 | $7.58M | 2,535,115 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 12,311 | $13.50 | $166.2K | 280,294 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 89,145 | $13.50 | $1.20M | 2,029,495 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 43,550 | — | $0 | 267,983 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 315,328 | — | $0 | 1,940,350 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 60,813 | — | $0 | 224,433 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 440,119 | — | $0 | 1,625,022 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 65,552 | — | $0 | 163,620 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 474,713 | — | $0 | 1,184,903 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 98,068 | — | $0 | 98,068 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 710,190 | — | $0 | 710,190 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | J Other deriv | 2021-04-22 | 2021-04-26 | 0 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | J Other deriv | 2021-04-22 | 2021-04-26 | 0 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 364,138 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 98,484 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 713,203 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 50,282 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 944,056 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 17,711 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 472,296 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,092,080 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 5,655 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 47,718 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 43,901 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 150,802 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 40,953 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 345,568 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 317,922 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 357,353 | $17.00 | $6.08M | 357,353 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 14,275 | $17.00 | $242.7K | 281,223 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 266,948 | — | $0 | 266,948 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 1,933,185 | — | $0 | 1,933,185 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 103,372 | $17.00 | $1.76M | 2,036,557 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 144 | $20.00 | $2.9K | 1,821,483 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 40,953 | $0.07 | $2.9K | 1,821,627 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 345,568 | — | $0 | 1,780,674 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 317,922 | — | $0 | 1,435,106 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,092,080 | — | $0 | 1,117,184 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 62 | $20.00 | $1.2K | 1,448,286 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 17,711 | $0.07 | $1.2K | 1,448,348 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 472,296 | — | $0 | 1,430,637 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 175,733 | $20.00 | $3.51M | 1,997,216 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 150,802 | — | $0 | 154,268 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 43,901 | — | $0 | 198,169 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 47,718 | — | $0 | 245,887 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 5,655 | $0.07 | $396 | 251,542 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 20 | $20.00 | $400 | 251,522 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 24,267 | $20.00 | $485.3K | 275,789 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 150,000 | $20.00 | $3.00M | 150,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 944,056 | — | $0 | 958,341 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,885,611 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 260,380 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 523,726 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 224,054 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 30,939 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 72,320 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 260,380 | — | $0 | 260,380 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 1,885,611 | — | $0 | 1,885,611 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | P Buy | 2020-10-20 | 2020-10-20 | 483,267 | $15.00 | $7.25M | 3,116,658 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 30,939 | — | $0 | 363,639 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 72,320 | — | $0 | 332,700 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | P Buy | 2020-10-20 | 2020-10-20 | 66,733 | $15.00 | $1.00M | 430,372 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 224,054 | — | $0 | 2,633,391 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 523,726 | — | $0 | 2,409,337 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-17 | 2020-04-17 | 74,333 | $15.40 | $1.14M | 2,162,587 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-17 | 2020-04-17 | 10,265 | $15.40 | $158.1K | 298,625 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-16 | 2020-04-17 | 26,527 | $15.20 | $403.2K | 2,236,920 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-16 | 2020-04-17 | 3,663 | $15.20 | $55.7K | 308,890 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-15 | 2020-04-17 | 26,185 | $15.50 | $405.9K | 312,553 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-15 | 2020-04-17 | 189,625 | $15.50 | $2.94M | 2,263,447 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-07 | 2020-04-07 | 742 | $14.20 | $10.5K | 338,738 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-07 | 2020-04-07 | 5,373 | $14.20 | $76.3K | 2,453,072 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-03 | 2020-04-07 | 36,400 | $13.80 | $502.3K | 339,480 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-04-03 | 2020-04-07 | 263,600 | $13.80 | $3.64M | 2,458,445 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 48 | $19.50 | $936 | 375,880 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 133 | $19.50 | $2.6K | 168,165 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 347 | $19.50 | $6.8K | 2,722,045 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 200 | $21.40 | $4.3K | 375,928 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 5,904 | $21.40 | $126.3K | 168,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 1,451 | $21.40 | $31.1K | 2,722,392 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 4,614 | $22.00 | $101.5K | 174,202 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 157 | $22.00 | $3.5K | 376,128 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 1,134 | $22.00 | $24.9K | 2,723,843 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 10,519 | $22.80 | $239.8K | 178,816 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 2,584 | $22.80 | $58.9K | 2,724,977 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 357 | $22.80 | $8.1K | 376,285 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 143 | $21.70 | $3.1K | 376,642 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 4,220 | $21.70 | $91.6K | 189,335 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 1,037 | $21.70 | $22.5K | 2,727,561 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 5,940 | $22.10 | $131.3K | 193,555 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 201 | $22.10 | $4.4K | 376,785 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 1,459 | $22.10 | $32.2K | 2,728,598 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 2,673 | $22.20 | $59.3K | 2,730,057 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 369 | $22.20 | $8.2K | 376,986 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 10,878 | $22.20 | $241.5K | 199,495 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 40,407 | $22.25 | $899.1K | 377,355 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 292,609 | $22.25 | $6.51M | 2,732,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 83,984 | $22.25 | $1.87M | 210,373 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 8,424,416 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 187,648 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 1,358,903 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 1,163,311 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 57,035 | — | $0 | 410,625 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 413,040 | — | $0 | 2,973,653 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 51,686 | $17.00 | $878.7K | 3,025,339 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 7,137 | $17.00 | $121.3K | 417,762 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 141,177 | $17.00 | $2.40M | 141,177 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 153,180 | $20.73 | $3.18M | 294,357 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 2,560,613 | — | $0 | 2,560,613 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 353,590 | — | $0 | 353,590 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 6,335,215 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 874,817 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 2,475,118 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 341,784 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 126,703 | — | $0 | 486,695 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 917,559 | — | $0 | 3,524,541 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 324,306 | — | $0 | 359,992 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 2,348,550 | — | $0 | 2,606,982 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | P Buy | 2018-01-25 | 2018-01-29 | 35,686 | $17.00 | $606.7K | 35,686 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | P Buy | 2018-01-25 | 2018-01-29 | 258,432 | $17.00 | $4.39M | 258,432 | SEC↗ |